Skip to content
Screener

Gross Profit at other companies

AbbVie logo
AbbVieABBV
$12.7B+14.6%
Ocular Therapeutix logo
Ocular TherapeutixOCUL
$9.46M+0.2%
HRO
HarrowHROW
$27.05M-16.3%
Warby Parker logo
Warby ParkerWRBY
$136.46M+20.1%
Journey Medical Corporation logo
Journey Medical CorporationDERM
$9.74M+16.7%
PTH
Pelthos TherapeuticsPTHS
$9.23M

Other financials

Income statement

See full
Revenue$173.9M+69.4%
Operating income-$19.9M+10.3%
Net income-$18.6M+8.8%
EPS (diluted)-$0.43+10.4%

Balance sheet

See full
Cash & equivalents$206.6M+108%
Total debt$88.8M+22.6%
Total equity$346.7M+4.2%
Total assets$611.1M+23.5%

Cash flow

See full
Operating cash flow$61.2M+308%
CapEx$4.1M+306%
Free cash flow$57.2M+288%

Valuation

See full
Market cap$2.87B+63.9%
Enterprise value$2.75B+59.6%
P/S4.7×-1.2×

Profitability

See full
Gross margin79.8%
Operating margin-8%-3.5pp
Net margin-7.7%-3.3pp
FCF margin-28%-12.6pp

Returns & leverage

See full
Return on equity-13.7%-4.9pp
Debt / equity0.3×0.0×
Current ratio3.2×-2.1×

Where this comes from

Calculated from Tarsus Pharmaceuticals, Inc.’s reported figures.

The source filing: Tarsus Pharmaceuticals, Inc.’s 10-Q, filed August 6, 2026. Open the filing →

Filed
Aug 6, 2026, 7:25 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001819790-26-000064

FAQ

What is Tarsus Pharmaceuticals, Inc.'s gross profit?
Tarsus Pharmaceuticals, Inc. (TARS) reported gross profit of $161.8M in Q2 2026.
How has Tarsus Pharmaceuticals, Inc.'s gross profit changed year-over-year?
Tarsus Pharmaceuticals, Inc.'s gross profit increased by 67.8% year-over-year, from $96.42M to $161.8M.
What does gross profit mean?
Revenue minus cost of revenue — the profit available to cover operating expenses, representing the company's pricing power and production efficiency.

Ask your AI about Tarsus Pharmaceuticals, Inc.'s gross profit.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude